SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-024723
Filing Date
2023-07-17
Accepted
2023-07-17 16:15:14
Documents
12
Period of Report
2023-07-12
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34371
  Complete submission text file 0001493152-23-024723.txt   208598

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hils-20230712.xsd EX-101.SCH 3030
3 XBRL LABEL FILE hils-20230712_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hils-20230712_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3417
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 231091768
SIC: 2834 Pharmaceutical Preparations